Minerva Neurosciences (NERV) Institutional Ownership $2.25 +0.46 (+25.35%) Closing price 08/15/2025 03:59 PM EasternExtended Trading$2.26 +0.02 (+0.67%) As of 08/15/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Minerva Neurosciences (NASDAQ:NERV)CurrentInstitutional OwnershipPercentage34.56%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$84.69KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$64.60K Get NERV Insider Trade Alerts Want to know when executives and insiders are buying or selling Minerva Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NERV Institutional Buying and Selling by Quarter Minerva Neurosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/10/2025 Apella Capital LLC20,625$35K0.0%N/A0.295% 2/17/2025 Citadel Advisors LLC25,764$57K0.0%+49.5%0.369% 2/14/2025 Northern Trust Corp36,878$82K0.0%+60.0%0.528% 2/13/2025 Renaissance Technologies LLC128,100$285K0.0%-18.5%1.833% 8/9/2024 Renaissance Technologies LLC167,700$535K0.0%-5.7%2.398% 11/13/2023 Acadian Asset Management LLC17,423$120K0.0%-18.8%0.249% 8/7/2023 Acadian Asset Management LLC21,463$195K0.0%-24.3%0.307% 7/27/2023 Virtu Financial LLC20,993$192K0.0%N/A0.377% 11/14/2022 Point72 Asset Management L.P.25,000$231K0.0%N/A0.468% 10/26/2022 Truist Financial Corp11,043$102K0.0%N/A0.207% Get the Latest News and Ratings for NERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 9/16/2022 Federated Hermes Inc.1,201,275$3.98M0.0%-87.5%22.496% 2/10/2022 Acadian Asset Management LLC1,768,685$1.41M0.0%+3.4%4.140% 11/16/2021 Two Sigma Securities LLC16,788$29K0.0%N/A0.039% 11/15/2021 Dimensional Fund Advisors LP740,056$1.29M0.0%-30.7%1.732% 11/15/2021 GSA Capital Partners LLP480,629$836K0.1%+26.0%1.125% 11/12/2021 Renaissance Technologies LLC754,116$1.31M0.0%-24.7%1.765% 11/12/2021 Connor Clark & Lunn Investment Management Ltd.143,761$250K0.0%+33.3%0.337% 11/10/2021 Rafferty Asset Management LLC48,865$85K0.0%N/A0.114% 11/9/2021BlackRock Inc.488,370$850K0.0%+20.2%1.143% 11/2/2021Raymond James Financial Services Advisors Inc.17,000$30K0.0%-54.1%0.040% 10/19/2021 Assenagon Asset Management S.A.1,082,333$1.88M0.0%+44.5%2.533% 9/17/2021 Virtu Financial LLC15,389$36K0.0%N/A0.036% 8/17/2021 Millennium Management LLC1,294,444$3.00M0.0%+126.5%3.030% 8/17/2021 Bridgeway Capital Management LLC89,200$207K0.0%-61.8%0.209% 8/16/2021 Squarepoint Ops LLC15,578$36K0.0%N/A0.036% 8/16/2021 AQR Capital Management LLC52,822$123K0.0%-69.3%0.124% 8/16/2021 LMR Partners LLP31,189$72K0.0%N/A0.073% 8/16/2021 State Street Corp110,632$257K0.0%-80.6%0.259% 8/16/2021Tibra Equities Europe Ltd136,100$316K0.1%N/A0.319% 8/16/2021 Goldman Sachs Group Inc.97,564$227K0.0%-89.8%0.228% 8/13/2021 Renaissance Technologies LLC1,001,844$2.32M0.0%+128.2%2.345% 8/13/2021 Northern Trust Corp68,097$158K0.0%-81.5%0.159% 8/13/2021 Jump Financial LLC65,600$153K0.0%N/A0.154% 8/13/2021 Qube Research & Technologies Ltd15,329$36K0.0%N/A0.036% 8/13/2021 Geode Capital Management LLC445,779$1.03M0.0%-35.8%1.043% 8/13/2021 Vanguard Group Inc.4,098,851$9.51M0.0%-7.3%9.594% 8/12/2021 XTX Topco Ltd34,202$79K0.0%N/A0.080% 8/12/2021 Dimensional Fund Advisors LP1,067,481$2.48M0.0%-1.9%2.499% 8/12/2021 JPMorgan Chase & Co.118,560$275K0.0%-36.0%0.278% 8/12/2021Ergoteles LLC162,100$376K0.0%N/A0.379% New law could create $3.7 trillion tsunami. (Ad)During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.You can watch it right here.8/12/2021 Connor Clark & Lunn Investment Management Ltd.107,874$250K0.0%+10.3%0.253% 8/11/2021 Bank of New York Mellon Corp30,757$71K0.0%-74.4%0.072% 8/11/2021 Deutsche Bank AG114,523$266K0.0%+16.6%0.268% 8/5/2021 Los Angeles Capital Management LLC49,945$116K0.0%-73.3%0.117% 8/5/2021 GSA Capital Partners LLP381,488$885K0.1%+187.5%0.893% 8/4/2021 Russell Investments Group Ltd.94,688$218K0.0%-7.6%0.222% 5/18/2021Morgan Stanley929,176$2.71M0.0%+92.2%2.175% 5/18/2021 Cubist Systematic Strategies LLC17,598$51K0.0%+49.2%0.041% (Data available from 1/1/2016 forward) NERV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NERV shares? During the previous two years, the following institutional investors and hedge funds held shares of Minerva Neurosciences shares: Renaissance Technologies LLC ($285K), Acadian Asset Management LLC ($120K), Northern Trust Corp ($82K), and Citadel Advisors LLC ($57K), Apella Capital LLC ($35K).Learn more on Minerva Neurosciences' institutional investors. What percentage of Minerva Neurosciences' stock is owned by institutional investors? 34.56% of Minerva Neurosciences' stock is owned by institutional investors. Learn more on NERV's institutional investor holdings. Which institutional investors have been buying Minerva Neurosciences' stock? The following institutional investors have purchased Minerva Neurosciences' stock in the last 24 months: Apella Capital LLC ($20.63K), Northern Trust Corp ($13.83K), and Citadel Advisors LLC ($8.53K). How much institutional buying is happening at Minerva Neurosciences? Institutional investors have bought a total of 42,979 shares in the last 24 months. This purchase volume represents approximately $84.69K in transactions. Which of Minerva Neurosciences' major shareholders have been selling company stock? The following institutional investors have sold Minerva Neurosciences stock in the last 24 months: Renaissance Technologies LLC ($29.10K). How much institutional selling is happening at Minerva Neurosciences? Institutional investors have sold a total of 29,100 shares in the last 24 months. This volume of shares sold represents approximately $64.60K in transactions. Related Companies Galapagos Major Shareholders Indivior Major Shareholders InterCure Major Shareholders Neonc Technologies Major Shareholders This page (NASDAQ:NERV) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access